From DREAM to DREAM 2.0: An African Model

  • Maria Cristina MarazziEmail author
Part of the TELe-Health book series (TEHE)


Towards the end of the 1990s, the local governments and the World Health Organisation itself identified prevention as the only possible way to counter HIV/AIDS in Africa.

Starting from the clearly wrong healthcare decisions that had been made up to then, a group of doctors who also carried out research, from the Community of Sant’Egidio, suggested that prevention had to be combined with therapy, as a natural complement in reducing the number of new infections, which was the approach in the western part of the world.

So in 2002 the DREAM (Drug Resource Enhancement against AIDS and Malnutrition) programme was set up in Mozambique, at first only for the prevention and treatment of HIV and the fight against malnutrition. Today, after 15 years DREAM 2.0 (Disease Relief through Excellent and Advanced Means) has become a model for fighting not only HIV/AIDS but also other infectious diseases and many chronic pathologies that are increasing fast in Africa. This healthcare model is present in 47 health centres in 11 countries in Africa and treats 350,000 patients.


Dream programme Community of S. Egidio HIV AIDS 


  1. 1.
    Morozzo della Rocca R. Limes rivista Italiana di geopolitica. Sant’Egidio: la via romana alla pace, 1993. Available on
  2. 2.
    Adler MW. Antiretrovirals for developing world. The Lancet. January 24, 1998; 351.Google Scholar
  3. 3.
    Hirshel B. Progress and problems in the fight against AIDS. N Engl J Med. 1998;338(13):906–8.CrossRefGoogle Scholar
  4. 4.
    Brown D. With fanfare, global aids conference gets underway in Vancouver. Washington Post, 8/07/1996.Google Scholar
  5. 5.
    Zeit P. Lessons from South Africa’s experience of HIV/AIDS. The Lancet. 2007;370(9581):19–20.CrossRefGoogle Scholar
  6. 6.
    Royce RA, et al. Sexual transmission of HIV. N Engl J Med. 1997;336(15):1072–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Quinn TC, et al. for the Rakai Project Study Group. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 2000;342:921–9.Google Scholar
  8. 8.
    Simelela NP, et al. A brief history of South Africa’s response to AIDS. S Afr Med J. 2014;104(3 Suppl 1):249–51.CrossRefPubMedGoogle Scholar
  9. 9.
    Furman K. Mbeki’s AIDS denialism: Thabo Mbeki’s support of dissident HIV/AIDS scientists is a cautionary tale for policy makers dealing with competing sets of evidence. Think Africa Press; 17 November 2011.Google Scholar
  10. 10.
    UNAIDS. Report on the global HIV/AIDS epidemic. Luglio 2002.Google Scholar
  11. 11.
    Lange J. Talking at the closing ceremony of the 14th IAS Conference. Barcellona Luglio; 2002.Google Scholar
  12. 12.
    WHO. Comunità di Sant’Egidio DREAM. An integrated faith-based initiative to treat HIV/AIDS in Mozambique. Case Study. Perspectives and Practice in Antiretroviral Treatment, Ginevra; 2005.Google Scholar
  13. 13.
    Statement by Stephen Lewis, UN Special Envoy for HIV/AIDS in Africa, on World AIDS Day, December 1, 2005.Google Scholar
  14. 14.
    “Adult Guideline Development Group” and “External Peer Reviewers” guideline WHO treatment HAART June 2003. WHO, Consolidated guidelines on the use of Antiretroviral drugs for treating and preventing HIV infection. Recommendations for a public health approach, Ginevra; 2013.Google Scholar
  15. 15.
    I sogni crescono: DREAM 2.0 ovvero Disease Relief through Excellent and Advanced Means 25 giugno 2015. Available on

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Humanities – Communication, Education, PsychologyLUMSA UniversityRomeItaly

Personalised recommendations